Scroll To Top
Search by Speciality

3RD EUROPEAN ASSOCIATION FOR CANCER RESEARCH (EACR) CONFERENCE ON CELL DEATH IN CANCER

De Rode Hoed’s Great Hall | Amsterdam, NETHERLANDS
From 300 to 380 EUR
Event Preview
EXPIRED
This event
is Finished
Title: 3RD EUROPEAN ASSOCIATION FOR CANCER RESEARCH (EACR) CONFERENCE ON CELL DEATH IN CANCER
Specialty: Medical Oncology
Dates: From Jan, 28, 2016 to Jan, 30, 2016
Location: Amsterdam, NETHERLANDS
Type: Conference
Registration Cost: From 300 to 380 EUR
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Jan
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for AMSTERDAM, Netherlands.
General Info
Event Venue:

De Rode Hoed’s Great Hall

AMSTERDAM, NETHERLANDS Visit the Venue to read more
Currency:
EUR
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

Introduction

The EACR Conference "A Matter of Life or Death: Mechanisms and Relevance of Cell Death for Cancer Biology and Treatment" is the third conference on this topic. Its objective is to cover recent and exciting developments in the field that are crucial to our understanding of the multifaceted role of cell death in tumour initiation, progression and therapy response.

Target audience

This meeting is of interest to scientists from different fields of cancer research, such as cancer biology, molecular pathology, molecular oncology, cancer immunology, pharmacology, radiation biology and oncology, and medical oncology, as it will cover the multifaceted role of cell death in cancer ranging from basic mechanisms of cell death signalling and resistance, tumour microenvironment, tumour heterogeneity, and immune effects to target discovery and new therapy concepts. Given its translational character, the conference is of broad interest for basic, translational and clinical researchers as well as for companies. We will provide ample opportunities for early stage basic and translational cancer researchers and young medical oncologists to present their work to the international community and to meet experts in the field in an inspiring informal atmosphere to share research findings and to establish or strengthen collaborations.

Download and share

with colleagues

document_a4

A4 promotional leaflet

Background

Although our understanding of the mechanisms of apoptotic and non-apoptotic programmed cell death modes has increased enormously during the last decade, successful translation of our knowledge into clinical application to the benefit of patients is still challenging. Research about the mechanisms of classical and non-classical modes of programmed cell death, and their dual role in tumour development and therapy response is a rapidly evolving field that has enormous impact on the development and implementation of novel treatment strategies.

Induction of cell death is the molecular basis of the cytotoxic action of many chemotherapeutic drugs and radiotherapy. Conversely, evading programmed cell death has been recognised as one major hallmark of cancer cells thereby contributing to therapy resistance. Cancer cells may even hijack tumour suppressor mechanisms like protective autophagy to survive adverse conditions in the tumour microenvironment. Otherwise, the mode of cell death is also an important determinant of the immune response resulting from therapy-induced tissue damage that may either increase the antitumor effect or be tumour promoting.

Topics to be covered

The various modes of programmed cell death and their regulation, e.g. apoptosis, autophagy and necroptosis;

Cancer cell autonomous TRAIL-receptor signaling and cancer progression;

Ouroborous, autophagy and growth control;

The interplay of p53-mediated apoptosis and tumour suppression;

The protein interaction map of apoptosis and autophagy;

Autophaghy and cancer metabolism;

Importance and therapeutic exploitation of the cellular stress response, the ubiquitin proteasome system and cell death signalling for cancer therapy;

In vivo RNAi screening for the identification of new resistance mechanisms;

Precision cancer therapy targeting mitochondria;

New strategies to kill cancer stem cells;

Therapeutic targets in DNA repair;

Therapeutic reprograming of radiation-induced immune deviation in normal tissue responses.

Registration Needs updating Register Now
Currency:

EUR

Registration Cost
Type
Early Registration

2015-12-15
Late Registration From: 2015-12-16 To: 0--
On site Registration
EACR member
340
380
0
Student
300
325
0

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts

Accommodation
Accommodation:

De Rode Hoed is a historic building in the picturesque heart of Amsterdam. De Rode Hoed’s Great Hall is the largest and oldest remaining hidden church in the Netherlands and a perfect setting for a meeting and informal open discussion.

The route from to de Rode Hoed from Amsterdam Central Station and nearby parking garages (see below)

Map

Keizersgracht 102

1015 CV AMSTERDAM

Tel: 020-6385606

Fax: 020-6254452

w: www.rodehoed.nl

e: info@rodehoed.nl

Travelling to and from the Airport

The train station at Schipol Airport is easily accessed by lifts or escalators in the terminal building. There are very regular trains to the Amsterdam Central Station. Tickets can be purchased from ticket machines using a credit card and we recommend spending a little extra to take the fast route with no stops between the airport and the station. The journey takes less than 15 minutes.

Scientific Content Up to Date
Submission Info

9 proffered papers will be selected from submitted abstracts for oral presentation.

All abstracts will be reviewed by the Scientific Programme Committee and successful delegates will be notified of their poster or oral presentation as soon as possible after the deadline.

Poster specifications: Poster Boards are 1m by 2m in Portrait. Your poster should be no greater than 90cm x 140cm in Portrait. You can attach your poster with drawing pins or double-sided Velcro tape which will be provided for you.

Sponsors Exhibitors
General Info

This meeting is of interest to scientists from different fields of cancer research, such as cancer biology,

molecular pathology, molecular oncology, cancer immunology, pharmacology, radiation biology and

oncology, and medical oncology, as it will cover the multifaceted role of cell death in cancer ranging from

basic mechanisms of cell death signalling and resistance, tumour microenvironment, tumour

heterogeneity, and immune effects to target discovery and new therapy concepts. Given its translational

character, the conference is of broad interest for basic, translational and clinical researchers as well as for

companies.

We expect around 150 participants. The venue (a converted former church) allows us to accommodate

an exhibition of 7 stands.

Partnership Sponsor with Satellite Presentation: €2,000 (1 available)

 Satellite Session for 30 minutes on Friday 29 January

o Promotional support to assist in obtaining good attendance at the Satellite Session, which

includes a detailed announcement in a special promotional email to all conference

participants

o Opportunity to display promotional banners at the front of the main auditorium for the

duration of the Satellite Session

 Prime exhibition space within the exhibition area including 1 table and 2 chairs

 2 complimentary registrations including Conference Dinner on Friday 29 January. For extra stand

staff please see overleaf.

 1 A4 full page colour advertisement in the printed and online Conference Programme Book

 Partnership Sponsorship and Satellite Session details highlighted in the printed and online

Conference Programme Book

 Company logo and website link featured on conference website

 After the conference an updated delegate list will be provided for a single post-conference mailing

Contact
Organising Agency

This conference is organised by the European Association for Cancer Research as part of the EACR Conference Series.

If you have any queries that are not answered on this website or in the Frequently Asked Questions, please contact us using the details below.

Kathryn Wass

EACR Conference Series Manager

European Association for Cancer Research

Sir Colin Campbell Building

University of Nottingham Innovation Park

Triumph Road

Nottingham NG7 2TU

United Kingdom

Tel: +44 (0) 115 9515114 

Fax: +44 (0) 115 9515115

E-mail: kathryn.wass@nottingham.ac.uk

Website: www.eacr.org

 

Event map
Revelant Events